Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET - Concepedia

Concepedia

Publication | Open Access

Diagnosis of Pseudoprogression Following Lomustine–Temozolomide Chemoradiation in Newly Diagnosed Glioblastoma Patients Using FET-PET

DOI Full Paper Access

36

Citations

50

References

2021

Year

Jan‐Michael Werner, Johannes Weller, Garry Ceccon, Christina Schaub, Caroline Tscherpel, Philipp Lohmann, Elena K. Bauer, Niklas Schäfer, Gabriele Stoffels, Christian Baues,

Clinical Cancer Research

Abstract

The data suggest that FET-PET parameters are of significant clinical value to diagnose pseudoprogression related to lomustine-temozolomide chemoradiation.

References

	Year	Citations

Page 1